shortagewatch

Home / Olanzapine / Germany

DE ATC N05AH03 · updated 2 Nov 2026

Olanzapine shortage in Germany

Is there an Olanzapine shortage in Germany?

Yes. As of 2 Nov 2026, 8 Olanzapine products are reported short in Germany, the first since 1 Apr 2026. The company estimate for the return is 13 Nov 2026 (latest 31 Dec 2026). Main reason: manufacturing problem.

Also short in Canada, France, Italy, Spain, Ireland, Austria, Belgium, Czechia, Norway, Sweden, New Zealand, Australia. All countries.

Affected products in Germany

CountryProductCompanySinceExpected backReason
DEOLANZAPIN BASICS 10 mg TablettenBasics GmbH1 Apr 202631 Dec 2026Manufacturing problem
Produktionsproblem
DEOLANZAPIN BASICS 10 mg TablettenBasics GmbH1 Apr 202631 Dec 2026Manufacturing problem
Produktionsproblem
DEOLANZAPIN BASICS 2,5 mg TablettenBasics GmbH2 Apr 202631 Dec 2026Active ingredient shortage
Probleme beim Wirkstoffhersteller
DEOLANZAPIN BASICS 5 mg TablettenBasics GmbH17 Jul 202631 Dec 2026Manufacturing problem
Produktionsproblem
DEOlanzapin Glenmark 2,5 mg Tabletten - OP70Glenmark Arzneimittel GmbH3 Aug 202613 Nov 2026Increased demand
Erhöhte Nachfrage
DEZYPADHERA 210 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension - OP(483mg+3ml)Cheplapharm Registration GmbH19 Sep 20262 Dec 2026Manufacturing problem
Probleme in der Herstellung
DEOlanzapin Glenmark 2,5 mg Tabletten - OP56Glenmark Arzneimittel GmbH21 Sep 202613 Nov 2026Increased demand
Erhöhte Nachfrage
DEOlanzapin Glenmark 20 mg Tabletten - OP70Glenmark Arzneimittel GmbH21 Sep 202627 Nov 2026Increased demand
Erhöhte Nachfrage

Source

BfArM (Federal Institute for Drugs and Medical Devices), via PharmNet.Bund. Official list. Supply-relevant medicines reported under a voluntary self-commitment; mostly hospital-relevant products.